| Schedule of Segment Information |
Segment information for the year ended December
31, 2025 was as follows:
| | |
Year Ended December 31, 2025 | |
| | |
Health Services | | |
Digital Healthcare | | |
Medical Distribution | | |
Total | |
| Revenue | |
| | |
| | |
| | |
| |
| Patient service revenue, net | |
$ | 2,002,548 | | |
$ | – | | |
$ | – | | |
$ | 2,002,548 | |
| Subscription revenue | |
| – | | |
| 22,623 | | |
| – | | |
| 22,623 | |
| Product and other revenue | |
| – | | |
| – | | |
| 40,121 | | |
| 40,121 | |
| Total revenue | |
| 2,002,548 | | |
| 22,623 | | |
| 40,121 | | |
| 2,065,292 | |
| | |
| | | |
| | | |
| | | |
| | |
| Operating Expenses | |
| | | |
| | | |
| | | |
| | |
| Practice salaries and benefits | |
| 1,016,543 | | |
| – | | |
| – | | |
| 1,016,543 | |
| Other practice operating expenses | |
| 973,048 | | |
| – | | |
| – | | |
| 973,048 | |
| Cost of product revenue | |
| – | | |
| – | | |
| 51,568 | | |
| 51,568 | |
| Selling, general and administrative expenses | |
| – | | |
| 2,007,845 | | |
| 27,671 | | |
| 2,035,516 | |
| Depreciation and amortization | |
| 97,175 | | |
| 4,696 | | |
| – | | |
| 101,871 | |
| Total Operating Expenses | |
| 2,086,766 | | |
| 2,012,541 | | |
| 79,239 | | |
| 4,178,546 | |
| | |
| | | |
| | | |
| | | |
| | |
| Income (loss) from operations | |
$ | (84,218 | ) | |
$ | (1,989,918 | ) | |
$ | (39,118 | ) | |
$ | (2,113,254 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Other Segment Information | |
| | | |
| | | |
| | | |
| | |
| Gain on extinguishment of debt | |
$ | – | | |
$ | (317,982 | ) | |
$ | – | | |
$ | (317,982 | ) |
| Loss on change in fair value of debt | |
$ | – | | |
$ | 618,208 | | |
$ | – | | |
$ | 618,208 | |
| Gain on sale of assets | |
$ | – | | |
$ | (168,722 | ) | |
$ | – | | |
$ | (168,722 | ) |
| Gain on change in fair value of derivative financial instruments | |
$ | – | | |
$ | (8,644 | ) | |
$ | – | | |
$ | (8,644 | ) |
| Amortization of original issue discounts on notes payable | |
$ | 12,022 | | |
$ | 815,984 | | |
$ | – | | |
$ | 828,006 | |
| Interest expense and other | |
$ | 3,051 | | |
$ | 213,083 | | |
$ | – | | |
$ | 216,134 | |
| | |
| | | |
| | | |
| | | |
| | |
| Identifiable Assets | |
| | | |
| | | |
| | | |
| | |
| Identifiable assets as of December 31, 2025 | |
$ | 182,146 | | |
$ | 1,519,025 | | |
$ | 1,175 | | |
$ | 1,702,346 | |
Segment information for the year ended December
31, 2024 was as follows:
| | |
Year Ended December 31, 2024 | |
| | |
Health Services | | |
Digital Healthcare | | |
Medical Distribution | | |
Total | |
| Revenue | |
| | |
| | |
| | |
| |
| Patient service revenue, net | |
$ | 2,872,177 | | |
$ | – | | |
$ | – | | |
$ | 2,872,177 | |
| Subscription revenue | |
| – | | |
| 32,425 | | |
| – | | |
| 32,425 | |
| Product and other revenue | |
| – | | |
| – | | |
| 103,759 | | |
| 103,759 | |
| Total revenue | |
| 2,872,177 | | |
| 32,425 | | |
| 103,759 | | |
| 3,008,361 | |
| | |
| | | |
| | | |
| | | |
| | |
| Operating Expenses | |
| | | |
| | | |
| | | |
| | |
| Practice salaries and benefits | |
| 1,995,127 | | |
| – | | |
| – | | |
| 1,995,127 | |
| Other practice operating expenses | |
| 1,556,759 | | |
| – | | |
| – | | |
| 1,556,759 | |
| Cost of product revenue | |
| – | | |
| – | | |
| 96,237 | | |
| 96,237 | |
| Selling, general and administrative expenses | |
| – | | |
| 2,974,130 | | |
| 64,806 | | |
| 3,038,936 | |
| Depreciation and amortization | |
| 277,866 | | |
| 5,084 | | |
| – | | |
| 282,950 | |
| Impairment loss | |
| 716,000 | | |
| – | | |
| – | | |
| 716,000 | |
| Total Operating Expenses | |
| 4,545,752 | | |
| 2,979,214 | | |
| 161,043 | | |
| 7,686,009 | |
| | |
| | | |
| | | |
| | | |
| | |
| Loss from operations | |
$ | (1,673,575 | ) | |
$ | (2,946,789 | ) | |
$ | (57,284 | ) | |
$ | (4,677,648 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Other Segment Information | |
| | | |
| | | |
| | | |
| | |
| Loss on extinguishment of debt | |
$ | – | | |
$ | 178,986 | | |
$ | – | | |
$ | 178,986 | |
| Change in fair value of debt | |
$ | – | | |
$ | (84,109 | ) | |
$ | – | | |
$ | (84,109 | ) |
| Amortization of original issue discounts on notes payable | |
$ | 5,007 | | |
$ | 1,311,158 | | |
$ | – | | |
$ | 1,316,165 | |
| Gain from realization of contingent sale consideration receivable | |
$ | – | | |
$ | (125,355 | ) | |
$ | – | | |
$ | (125,355 | ) |
| Interest expense and other | |
$ | 11,506 | | |
$ | 156,638 | | |
$ | – | | |
$ | 168,144 | |
| | |
| | | |
| | | |
| | | |
| | |
| Identifiable Assets | |
| | | |
| | | |
| | | |
| | |
| Identifiable assets as of December 31, 2024 | |
$ | 496,391 | | |
$ | 1,719,020 | | |
$ | 7,578 | | |
$ | 2,222,989 | |
|